FIELD: medicine.
SUBSTANCE: universal liquid marker contains the sodium salt of fluorescein, anesthesin, ammonium larysulfate, methylparaben and distilled water.
EFFECT: implementation of the invention allows to provide an accurate assessment of suction and excretory ability of the nasal mucosa and maxillary sinus, significantly improve the efficiency of treatment, allowing to adjust the type and time of use of the prescribed medications.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LIQUID MARKER FOR DETERMINATION OF RESPIRATORY EPITHELIAL CLEARANCE SPEED OF NASAL MUCOSA AND MAXILLARY SINUS | 2016 |
|
RU2640174C2 |
| ADHESIVE POLYMERIC SOLUBLE FILM FOR DRUG DEPOSITION ON SURFACE OF NASAL AND SUPRA-LATERAL SINUS MUCOSA | 2016 |
|
RU2634259C1 |
| THERAPEUTIC ELIXIR FOR IRRIGATION OF THE MAXILLARY SINUS MUCOSA IN CASE OF OROANTHRAL INOSCULATION | 2016 |
|
RU2679919C2 |
| METHOD OF INVESTIGATING MUCOUS MEMBRANE OF NASAL CAVITY | 0 |
|
SU1242113A1 |
| METHOD OF MAXILLARY SINUS PUNCTURE | 2018 |
|
RU2702459C1 |
| METHOD FOR TREATING CHRONIC RHINOSINUSITIS | 2021 |
|
RU2781348C1 |
| WAY OF TREATMENT OF DISEASES OF PARANASAL OF SINUSES | 2008 |
|
RU2362592C1 |
| VASOMOTOR RHINITIS TREATMENT METHOD | 1997 |
|
RU2126701C1 |
| DIAGNOSTIC DEVICE FOR NASAL MUCOSA AND PARANASAL SINUS DISEASES | 2013 |
|
RU2547956C1 |
| DENTAL GEL FOR TREATING AND PREVENTING PERIODONTITIS | 2017 |
|
RU2703530C2 |
